{
  "index": 133,
  "timestamp": "2024-11-11 22:53:41",
  "original_text": "FDA approved changes to the DOVATO (dolutegravir/lamivudine) product labeling to include a new indication and provide longer term safety and efficacy data Get the latest update in HIV news More HIV Ne...",
  "qa_pairs": [
    {
      "text_input": "What is the new indication for DOVATO?",
      "output": "The text does not specify the new indication for DOVATO.",
      "index": 133,
      "timestamp": "2024-11-11 22:53:41"
    },
    {
      "text_input": "What is the duration of the longer term safety and efficacy data for DOVATO?",
      "output": "The text does not specify the duration of the longer term safety and efficacy data for DOVATO.",
      "index": 133,
      "timestamp": "2024-11-11 22:53:41"
    },
    {
      "text_input": "What is the purpose of the Center for Drug Evaluation and Research?",
      "output": "The text does not mention the purpose of the Center for Drug Evaluation and Research.",
      "index": 133,
      "timestamp": "2024-11-11 22:53:41"
    }
  ]
}